27.06.2011 • News

DSM Appoints New Chief Technology Officer

DSM has appointed Marcel Wubbolts, currently vice president R&D DSM Innovation Center, to the position of chief technology officer as of Oct.1, reporting to Rob van Leen, Chief Innovation Officer.

Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent Professor at the ETH in Zürich. He joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, in Jülich, Germany. Thereafter, he was competence manager Biocatalysis & Biotransformations and then became program director at the DSM Innovation Center in Delft, the Netherlands, running the Industrial (White) Biotechnology program

Marcel will succeed Jos Put who will continue to be an advisor to DSM e.g. in the field of material sciences and for several of the DSM Science and Technology awards.

 

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read